Primary Site >> Pancreatic Cancer
Gene >> CPB1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: A novel serum assay for pancreatic cellular damage. II. High tissue specificity of a pancreatic protein. PMID: 3222247 |
Ref: A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases. PMID: 1688389 |
Ref: Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA. PMID: 9261609 |
Ref: Polyplex micelles from triblock copolymers composed of tandemly aligned segments with biocompatible, endosomal escaping, and DNA-condensing functions for systemic gene delivery to pancreatic tumor tissue. PMID: 18781378 |
Ref: Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor. PMID: 19524625 Ref: Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series. PMID: 19588286 |
Ref: Poly(adenylic acid) complementary DNA real-time polymerase chain reaction in pancreatic ductal juice in patients undergoing pancreaticoduodenectomy. PMID: 19940796 |
Ref: Polyplex micelles prepared from omega-cholesteryl PEG-polycation block copolymers for systemic gene delivery. PMID: 20932567 |
Ref: PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor. PMID: 22066783 Ref: Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors. PMID: 22444644 |
Ref: Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety. PMID: 26763736 |
Ref: Polyplex micelle installing intracellular self-processing functionalities without free catiomers for safe and efficient systemic gene therapy through tumor vasculature targeting. PMID: 27835820 |
Ref: Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. PMID: 29669919 |